Clinically proven efficacy via7 clinical studies on skin prone to atopic eczema and skin prone to immune sensitivity.
82% of patients who use Lipikar Palm AB+M for one month do not relapse, compared to only 26% of those using standard care *.
*Clinical study conducted on 100 people I
Clinical study results of using Lipikar Syndet AB+ Body Cleanser in a daily routine*
- Itching was reduced by -41%.
- Insomnia and lack of sleep decreased by -42%
- Quality of life improved by +69%
*Clinical study conducted on 51 people (adults and children), during two weeks, using “Lipikar Balm AB+” and “Lipikar Balm AB+M”.
